3rd Drug Development Forum

October 1–3, 2018 | Hilton Boston Logan Airport Hotel

Executive-level networking for smarter partnerships and pipeline strategies, more effective development, and improved early research outcomes 
REGISTER NOW Group

FIERCEBIOTECH DRUG DEVELOPMENT FORUM

Where industry leaders set partnership and pipeline strategy

The FierceBiotech Drug Development Forum is an incomparable networking venue where hundreds of biotech C-suite decision makers tackle the greatest problems the industry faces in business development and early R&D. 

Our all-new program features unprecedented depth on managing VC relationships, beating ambitious growth plans, developing your immuno-oncology business model, adapting to new regulatory and pricing realities, and maintaining competitive advantage after the next market downturn. 

VIEW SCHEDULE Group
Graphic 1

View the Full Agenda

Featuring 90+ executive-level speakers and 35+ sessions
Group
Graphic 2

Join biotech leaders

Register now to benchmark & network with 300+ attendees
Group
Graphic 3

SPONSORSHIP OPPORTUNITIES

Share expertise, showcase your technologies, products & services
Group

2018 Featured Speakers

Stephane Bancel CEO MODERNA THERAPEUTICS
Stephane Bancel

CEO
MODERNA THERAPEUTICS

ROY BAYNES  Senior Vice President, Head of Clinical Development MERCK
Roy Baynes

CMO, Senior Vice President, Head of Clinical Development
MERCK

Lawrence Bloch President INFINITY PHARMACEUTICALS 
Lawrence Bloch

President
INFINITY PHARMACEUTICALS 

Nouhad Husseini Vice President, Head of Business Development REGENERON
Nouhad Husseini

Vice President, Head of Business Development
REGENERON

Douglas Ingram CEO SAREPTA THERAPEUTICS 
Douglas Ingram

CEO
SAREPTA THERAPEUTICS 

Ravi Kiron Head, BioPharma External Innovation EMD SERONO 
Ravi Kiron

Head, BioPharma External Innovation
EMD SERONO 

JULIE KROP CMO, AMAG PHARMACEUTICALS 
Julie Krop

CMO
AMAG PHARMACEUTICALS 

Salim Mujais Senior Vice President, Global Therapeutics Head, Specialty Pharma ASTELLAS 
Salim Mujais

Senior Vice President, Global Therapeutics Head, Specialty Pharma
ASTELLAS 

Sridhar Ramaswamy Vice President, Translational R&D TESARO
Sridhar Ramaswamy

Vice President, Translational R&D
TESARO

Aradhana Sarin Senior Vice President, Head of Business Development & Strategy ALEXION PHARMACEUTICALS
Aradhana Sarin

Senior Vice President, Head of Business Development & Strategy
ALEXION PHARMACEUTICALS

Jeremy Sohn Vice President, Global Head of Digital Business Development & Licensing NOVARTIS
Jeremy Sohn

Vice President, Global Head of Digital Business Development & Licensing
NOVARTIS

Zhen Su CMO EMD SERONO 
Zhen Su

CMO
EMD SERONO 

2018 KEYNOTE SPEAKERS

KEYNOTE: Pursue Breakthrough Approvals in Multiple Global Markets 
TUESDAY, OCTOBER 2, 2018

MODERATOR: Eric Palmer, Editor, FIERCEMARKETS 

Martine Zimmerman, Senior Vice President, Global Regulatory Affairs, ALEXION PHARMACEUTICALS 

Roy Baynes, CMO, Senior Vice President, Head of Clinical Development, MERCK 

Maria Fardis, CEO, IOVANCE 

Julian Adams, CEO, GAMIDA CELL 

LEARN MORE Group

Fierce 15 winners: What does it take to be fierce in today's biotech market?

2018 SPONSORING ORGANIZATIONS